Related Experiment Video
Updated: Aug 7, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Strategy to control methicillin-resistant Staphylococcus aureus post-operative infection in orthopaedic surgery
J C De Lucas-Villarrubia1, M Lopez-Franco, J J Granizo
1Department of Orthopaedic Surgery, Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Avda Reyes Catolicos 2, 28040, Madrid, Spain.
Abstract:
In the year 2000 the rate of infection after arthroplasty in our hospital was 9.75% and methicillin-resistant Staphylococcus aureus (MRSA) was the organism in 33% of the infected joints. In an attempt to overcome this unacceptable situation, we changed our prophylaxis regime over a period of 6 months. This involved modifying the precautionary measures for preventing surgical infections, active prophylaxis against any nasal reservoir of infection in joint implant patients, the control of health care personnel, the strict application of standard and contact precautions in all patients with MRSA, and the use of teicoplanin as prophylaxis during this 6-month period. This resulted in a definite decrease in the incidence of orthopaedic wound infections by MRSA, while the level of MRSA infection elsewhere in the hospital remained constant. Only one infection was detected during this 6-month trial, and this beneficial effect was maintained during the following 6 months. Since then, only sporadic new infections have been detected. Patients with arthroplasties performed during the study were followed for 12 months, and no new cases of MRSA infection were detected.
Insights
A new prophylaxis regimen significantly reduced methicillin-resistant Staphylococcus aureus (MRSA) infections following joint replacement surgery. This intervention proved effective in preventing post-arthroplasty MRSA infections during a 12-month follow-up.
Area of Science:
- Orthopaedic Surgery
- Infectious Disease Control
- Hospital Epidemiology
Background:
- High incidence of arthroplasty infections (9.75%) in 2000.
- Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 33% of these infections.
- Urgent need for effective infection control strategies.
Purpose of the Study:
- To implement and evaluate a revised prophylaxis regimen to reduce MRSA infections post-arthroplasty.
- To assess the impact of the new protocol on surgical site infections.
- To determine the sustained efficacy of the intervention.
Main Methods:
- Modified infection prevention measures.
- Active prophylaxis targeting nasal MRSA reservoirs.
- Enhanced healthcare personnel screening and control.
- Strict adherence to standard and contact precautions for MRSA patients.
- Use of teicoplanin prophylaxis during a 6-month trial period.
Main Results:
- Significant decrease in MRSA infections specifically within orthopaedic wound sites.
- MRSA infection rates remained stable in other hospital areas.
- Only one MRSA infection occurred during the 6-month trial.
- Sustained reduction in infections observed in the subsequent 6 months.
- No new MRSA infections detected in patients followed for 12 months post-arthroplasty.
Conclusions:
- The comprehensive prophylaxis strategy effectively reduced MRSA surgical site infections after arthroplasty.
- The intervention demonstrated a lasting positive impact on patient outcomes.
- This approach offers a viable solution for controlling MRSA in orthopaedic settings.
More Related Videos
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Asepsis
Hand hygiene
Hand washing...
Methods for Controlling Microbial Growth
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

